Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
122.9 USD | +0.84% | -2.33% | +23.35% |
May. 07 | UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating | MT |
May. 06 | News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.35% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-3.42% | 29.55B | |
+10.19% | 25.78B | |
-21.11% | 19.26B | |
-0.25% | 12.14B | |
+0.44% | 12.08B | |
+25.09% | 11.98B | |
+18.80% | 11.58B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna Reportedly Putting Plan for Kenya Vaccine Plant on Hold